Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Weber

Showing results (261-270 of 337) with videos related to

Pageof 34
Sort By:
Virology|January 15, 1996
The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutantR Martinez, L Shao, J C Bronstein, et al.
Biochimica Et Biophysica Acta|December 8, 1989
A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicatorR L Lorenz, W M Uedelhoven, S Fischer, et al.
Experimental and Clinical Cardiology|April 30, 2010
Association of myocardial infarction with mononuclear cell expression of the cytomegalovirus chemokine receptor US28 in patients with NIDDMC Weber, C von Stülpnagel, K S Weber, et al.
Klinische Wochenschrift|May 17, 1982
Arachidonic acid metabolites, hypertension and arteriosclerosisP C Weber, W Siess, B Scherer, et al.
Circulation|October 1, 1983
The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in manS Fischer, M Struppler, B Böhlig, et al.
Journal of Internal Medicine. Supplement|January 1, 1989
Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trialR Lorenz, P C Weber, P Szimnau, et al.
Thrombosis Research|October 15, 1993
Evidence for sustained platelet activation in patients with early postinfarction anginaD Hofmann, C W Hamm, R L Lorenz, et al.
Journal of Internal Medicine|June 1, 1990
A prospective study of the diagnostic value of urinary thromboxane in patients presenting with acute chest painR L Lorenz, C W Hamm, H Riesner, et al.
Biochemical Pharmacology|March 1, 1986
Effects on prostanoid formation and pharmacokinetics of dazmegrel (UK-38,485), a novel thromboxane synthase inhibitor, in manR L Lorenz, S Fischer, W Wober, et al.
European Journal of Immunology|April 1, 1993
Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cellsC Weber, M Aepfelbacher, H Haag, et al.
Pageof 34

Showing results (261-270 of 337) with videos related to

Sort By:
Pageof 34
Virology|January 15, 1996
The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutantR Martinez, L Shao, J C Bronstein, et al.
Biochimica Et Biophysica Acta|December 8, 1989
A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicatorR L Lorenz, W M Uedelhoven, S Fischer, et al.
Experimental and Clinical Cardiology|April 30, 2010
Association of myocardial infarction with mononuclear cell expression of the cytomegalovirus chemokine receptor US28 in patients with NIDDMC Weber, C von Stülpnagel, K S Weber, et al.
Klinische Wochenschrift|May 17, 1982
Arachidonic acid metabolites, hypertension and arteriosclerosisP C Weber, W Siess, B Scherer, et al.
Circulation|October 1, 1983
The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in manS Fischer, M Struppler, B Böhlig, et al.
Journal of Internal Medicine. Supplement|January 1, 1989
Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trialR Lorenz, P C Weber, P Szimnau, et al.
Thrombosis Research|October 15, 1993
Evidence for sustained platelet activation in patients with early postinfarction anginaD Hofmann, C W Hamm, R L Lorenz, et al.
Journal of Internal Medicine|June 1, 1990
A prospective study of the diagnostic value of urinary thromboxane in patients presenting with acute chest painR L Lorenz, C W Hamm, H Riesner, et al.
Biochemical Pharmacology|March 1, 1986
Effects on prostanoid formation and pharmacokinetics of dazmegrel (UK-38,485), a novel thromboxane synthase inhibitor, in manR L Lorenz, S Fischer, W Wober, et al.
European Journal of Immunology|April 1, 1993
Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cellsC Weber, M Aepfelbacher, H Haag, et al.
Pageof 34